Plain-English translation of NCT06944067 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →This is a genetic research study for people with sickle cell disease who have received blood transfusions. Researchers want to understand why some patients develop immune reactions (called alloimmunization) after transfusions while others don't. By comparing the genes of people who have had these reactions with those who haven't, scientists hope to identify which genetic factors put certain patients at higher risk.
Many patients with sickle cell disease need regular blood transfusions, but some develop immune reactions that make future transfusions harder to manage and less safe. Understanding the genetic reasons why this happens could help doctors predict which patients are at risk and find better ways to prevent or manage these reactions.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would donate a blood sample that researchers will use to study your genes and compare them with other participants' samples. This is an observational study, meaning researchers are watching and learning from your health history and genetics rather than testing a new treatment. Your medical records related to past transfusions and any immune reactions will also be reviewed as part of the research.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States